{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:30:57Z","timestamp":1792369857324,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.ophtha.2012.08.005","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T06:48:01Z","timestamp":1353394081000},"page":"379-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Visual Outcome, Treatment Results, and Prognostic Factors in Patients with Scleritis"],"prefix":"10.1016","volume":"120","author":[{"given":"Wietse G.","family":"Wieringa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap E.","family":"Wieringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninette H.","family":"ten Dam-van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonoor I.","family":"Los","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2012.08.005_bib1","first-page":"64","article-title":"The Sclera and Systemic Disorders","author":"Watson","year":"2004"},{"key":"10.1016\/j.ophtha.2012.08.005_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(91)32269-3","article-title":"Progression of scleral disease","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.08.005_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1442-9071.1991.tb00663.x","article-title":"Prediction of response to treatment in patients with scleritis using a standardised scoring system","volume":"19","author":"McCluskey","year":"1991","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","article-title":"Scleritis","volume":"50","author":"Okhravi","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0454","article-title":"Therapy insight: scleritis and its relationship to systemic autoimmune disease","volume":"3","author":"Smith","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00004397-198302310-00013","article-title":"Inflammation of the sclera","volume":"23","author":"Cobo","year":"1983","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2012.08.005_bib8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","article-title":"Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis","volume":"111","author":"Murphy","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.08.005_bib9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/bjo.2008.147157","article-title":"Rituximab for treatment of scleritis associated with rheumatoid arthritis","volume":"93","author":"Chauhan","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bjo.2008.150961","article-title":"Infliximab for the treatment of refractory scleritis","volume":"94","author":"Doctor","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09273941003739928","article-title":"Rituximab treatment for persistent scleritis associated with rheumatoid arthritis","volume":"18","author":"Iaccheri","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2012.08.005_bib12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bjo.2007.133173","article-title":"Rituximab for treatment of ocular inflammatory disease: a series of four cases","volume":"93","author":"Kurz","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10067-009-1368-8","article-title":"Successful treatment of severe nodular scleritis with adalimumab","volume":"29","author":"Restrepo","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib14","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3129\/i09-061","article-title":"Infliximab for the treatment of active scleritis","volume":"44","author":"Sen","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib16","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients","volume":"106","author":"McCluskey","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.08.005_bib17","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/archopht.121.11.1586","article-title":"Use of best and final visual acuity outcomes in ophthalmological research","volume":"11","author":"DiLoreto","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature","volume":"1","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bjo.2007.126425","article-title":"Immunopathology of necrotising scleritis","volume":"92","author":"Usui","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","article-title":"Evaluation of patients with scleritis for systemic disease","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"issue":"suppl","key":"10.1016\/j.ophtha.2012.08.005_bib21","first-page":"84","article-title":"Parallel studies of HLA antigens in patients with rheumatic heart disease and scleritis: comparisons with three control populations","volume":"3","author":"Joysey","year":"1977","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000101931","article-title":"Posterior scleritis and its association with HLA B27 haplotype","volume":"221","author":"Anshu","year":"2007","journal-title":"Ophthalmologica"},{"issue":"suppl","key":"10.1016\/j.ophtha.2012.08.005_bib23","first-page":"43","article-title":"A systematic comparison of rheumatoid arthritis and ankylosing spondylitis","volume":"27","author":"van der Horst-Bruinsma","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00055735-200112000-00013","article-title":"Systemic disorders associated with episcleritis and scleritis","volume":"12","author":"Pavesio","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajo.2007.11.010","article-title":"Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis","volume":"145","author":"Jachens","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib26","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"issue":"suppl","key":"10.1016\/j.ophtha.2012.08.005_bib27","first-page":"46","article-title":"Optimal administration and dosage of methotrexate","volume":"28","author":"Braun","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.23144","article-title":"Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial","volume":"58","author":"Braun","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2012.08.005_bib29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2008.094474","volume":"68","author":"Visser","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"suppl","key":"10.1016\/j.ophtha.2012.08.005_bib30","first-page":"27","article-title":"Methotrexate bioavailability","volume":"28","author":"van Roon","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.08.005_bib32","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0181-5512(05)81139-8","article-title":"Therapeutic decision in anterior scleritis: our experience at a tertiary care eye center","volume":"28","author":"Carrasco","year":"2005","journal-title":"J Fr Ophtalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012007609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012007609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:03:23Z","timestamp":1758981803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642012007609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0161642012007609"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.08.005","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visual Outcome, Treatment Results, and Prognostic Factors in Patients with Scleritis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}